Shattuck Labs (STTK) Other Working Capital Changes (2019 - 2026)
Shattuck Labs' (STTK) quarterly Other Working Capital Changes came in at -$225000.0 in Q1 2026, up 6.25% year-on-year from -$211764.7 in Q1 2025, and up 19.06% on a QoQ basis from -$278000.0 in Q4 2025.
Shattuck Labs (STTK) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Other Working Capital Changes data on file, last reported at -$225000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 6.25% year-over-year to -$225000.0 in Q1 2026; TTM through Mar 2026 was -$907000.0, a 2.16% increase from a year earlier, with the FY2025 full-year figure at -$922000.0, down 2.44% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$225000.0, up from -$278000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for STTK reached as high as $4.4 million in Q3 2022 and fell as low as -$11.8 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$1.2 million across 5 years, with a median of -$59000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 337.39% in 2023 and fell as far as 638.89% in 2023.
- Year by year, Other Working Capital Changes stood at -$185000.0 in 2022, then dropped by 12.97% to -$209000.0 in 2023, then slipped by 12.92% to -$236000.0 in 2024, then declined by 17.8% to -$278000.0 in 2025, then gained by 19.06% to -$225000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$225000.0 in Q1 2026, -$278000.0 in Q4 2025, and -$644000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -225,000.00 |
| Mar 31, 2026 | -225,000.00 |
| Mar 31, 2026 | -225,000.00 |
| Dec 31, 2025 | -278,000.00 |
| Dec 31, 2025 | -278,000.00 |
| Dec 31, 2025 | -278,000.00 |
| Sep 30, 2025 | -644,000.00 |
| Sep 30, 2025 | -644,000.00 |
| Sep 30, 2025 | -644,000.00 |
| Jun 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 240,000.00 |
| Mar 31, 2025 | -240,000.00 |
| Mar 31, 2025 | -240,000.00 |
| Mar 31, 2025 | -240,000.00 |
| Dec 31, 2024 | -236,000.00 |
| Dec 31, 2024 | -236,000.00 |
| Dec 31, 2024 | -236,000.00 |
| Sep 30, 2024 | -230,000.00 |
| Sep 30, 2024 | -230,000.00 |